期刊文献+

冠心病不同中医证型与血清NO的相关性研究 被引量:19

Correlative Study Between Plasma NO and Various TCM Syndromes in CHD
暂未订购
导出
摘要 目的检测冠心病不同中医证型血浆一氧化氮(NO)的水平,为冠心病的中医辨证分型提供客观依据。方法 165例冠心病患者按中医辨证分为心血瘀阻、痰浊壅塞、阴寒凝滞、心肾阴虚、气阴两虚、阳气虚衰6型,另设正常对照组30例;分别检测各组NO水平。结果冠心病患者各中医证型组NO值较正常对照组明显降低,具有统计学意义。各型间比较,痰浊壅塞型及心血瘀阻型显著低于其他各型,阳气虚衰型显著低于阴寒凝滞型、心肾阴虚型及气阴两虚型。NO值:痰浊壅塞型<心血瘀阻型<阳气虚衰型<阴寒凝滞型<心肾阴虚型<气阴两虚型<正常对照组。结论 NO水平与冠心病严重程度有一定关系,可作为中医辨证分型的参考指标。 Objective:To observe the changes of NO in different TCM syndromes of CHD patients and to provide the objective evidence of TCM syndromes differentiations.Methods:165 patients with CHD were divided into 6 syndormes including the stagnation of blood in heart syndrome,the retention of phlegm syndrome,the coagulation of cold syndrome,the deficiency of heart and kideny syndrome,the deficiency of qi and yin syndrome,the deficiency of yang and qi syndrome.Besides that,there were 30 patients in the control group.The levels of NO were observed in several groups.Results:The reductions of NO in the CHD patients were more significant than that in the control group.The NO levels of the retention of phlegm syndrome and the stagnation of blood in heart syndrome were lower obvious than those of the other syndromes.It in the deficiency of yang and qi syndrome was lower than those of tha coagulation of cold syndrome,the deficiency of heart and kidney syndrome.Conclusion:NO level gives a further demonstration that it is an indicator of the severity of CHD.It could be an objective proof for syndrome differentiation of TCM.
出处 《中国中医急症》 2011年第2期219-220,共2页 Journal of Emergency in Traditional Chinese Medicine
基金 湖南省卫生厅中医药科研基金项目(06102)
关键词 冠心病 辨证分型 一氧化氮 Coronary heart disease Syndrome differentiation NO
  • 相关文献

参考文献9

二级参考文献40

  • 1沈绍功.一切为了临床,疗效是硬道理——提升中医诊治冠心病疗效水准之浅识[J].中国医药学报,2004,19(10):587-589. 被引量:8
  • 2王静,吴时达.中药对血管内皮功能的保护作用[J].中国动脉硬化杂志,2005,13(1):116-118. 被引量:19
  • 3崔斌,黄岚,耿召华,方玉强,宋明宝,赵晓辉.人循环内皮祖细胞的分离培养和诱导分化[J].重庆医学,2006,35(5):420-422. 被引量:8
  • 4夏菁,陈光辉,刘宏斌.干细胞移植治疗在心血管疾病中应用的研究进展[J].中华老年心脑血管病杂志,2006,8(3):210-211. 被引量:2
  • 5[1]Celermajer D.Endothelial dysfunction:Does it matter?Is it reversible[J]?J Am Coll Cardiol,1997,30:325-333.
  • 6[2]Anderson TJ.Assessment and treatment of endothelium dysfunction in humans[J].J Am Coll Cardiol,1999,34:631-638.
  • 7[3]Braunwald E.Heart Disease:A Textbook of Cardiovascular Medicine[M].Fifth Edition:W.B.Sauders Company,1997.1020.
  • 8[4]Ascan W,Hanke M,Thomas H,et al.Adverse effects of nitrotyroglycerin treatment on endothelial function,vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic watanabe rabbits[J].J Am Coll Cardiol,2002,40(7):1356-1363.
  • 9[5]Bonetti PO,Wilson SH,Rodriguez-Porcel M,et al.Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering[J].J Am Coll Cardiol,2002,40:546-554.
  • 10[6]Wassmann S,Faul A,Hennen B.Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme,a reductase inhibition,on coronary endothelial function[J].Circ Res,2003,93(9):98-103.

共引文献128

同被引文献313

引证文献19

二级引证文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部